Phase 2 Small Cell Lung Cancer Extensive Stage trials recruiting now

All Small Cell Lung Cancer Extensive Stage trials, every phase

Other phases for Small Cell Lung Cancer Extensive Stage

Phase 2 Small Cell Lung Cancer Extensive Stage trials

• A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
  NCT07227597 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 52 locations
• First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
  NCT05745350 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• IN10018 Combination Therapy in Treatment-naïve ES-SCLC
  NCT06030258 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• Liposomal Irinotecan and Apatinib in ES-SCLC
  NCT06749691 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
  NCT06610734 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
  NCT06429696 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
  NCT05703971 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.